天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 83207-58-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 83207-58-3
Chemical Structure| 83207-58-3
Structure of 83207-58-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 83207-58-3 ]

Related Doc. of [ 83207-58-3 ]

Alternatived Products of [ 83207-58-3 ]
Product Citations

Product Details of [ 83207-58-3 ]

CAS No. :83207-58-3 MDL No. :MFCD00210476
Formula : C41H68O14 Boiling Point : No data available
Linear Structure Formula :- InChI Key :QMNWISYXSJWHRY-AUJDEUPOSA-N
M.W : 784.97 Pubchem ID :13943299
Synonyms :
Chemical Name :(2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-Hydroxy-3-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)hexadecahydrocyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Safety of [ 83207-58-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 83207-58-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 83207-58-3 ]

[ 83207-58-3 ] Synthesis Path-Downstream   1~10

  • 1
  • [ 108-24-7 ]
  • [ 83207-58-3 ]
  • [ 86764-16-1 ]
  • [ 86764-17-2 ]
  • 2
  • [ 76-83-5 ]
  • [ 83207-58-3 ]
  • C60H82O14 [ No CAS ]
  • 3
  • [ 86764-11-6 ]
  • [ 83207-58-3 ]
  • 4
  • [ 84676-88-0 ]
  • [ 83207-58-3 ]
  • 5
  • [ 84687-46-7 ]
  • [ 83207-58-3 ]
  • [ 86764-12-7 ]
  • 6
  • [ 84687-45-6 ]
  • [ 83207-58-3 ]
  • 7
  • [ 84687-47-8 ]
  • [ 83207-58-3 ]
  • 8
  • [ 83207-58-3 ]
  • [ 84605-18-5 ]
YieldReaction ConditionsOperation in experiment
64% With hydrogenchloride; In methanol; at 20℃; for 168h; To <strong>[83207-58-3]astragaloside IV</strong> (1) (5.00 g, mmol) was added ?HCl-MeOH 10? (TCI America) (500 mL) and the mixture was stirred at room temperature for 7 days. The reaction mixture was concentrated to about half volume under reduced pressure at 20 C. (do not heat). The mixture was partitioned into aqueous sodium bicarbonate and ethyl acetate. The aqueous layer was extracted with ethyl acetate again. The organic layers were combined, washed with saturated sodium chloride, dried on anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography (20:114:1 chloroform/methanol). In order to replace the residual solvent with ethanol, the purified material was dissolved in ethanol and the solvent was removed under reduced pressure to afford 2 (2.1 g, 64%).1H NMR (CDCl3) delta (ppm) 0.34 (d, J=4.7 Hz, 1H), 0.48 (d, J=4.3 Hz, 1H), 0.92 (s, 3H), 0.93 (s, 3H), 1.0-1.8 (m, 13H), 1.11 (s, 3H), 1.19 (s, 3H), 1.22 (s, 6H), 1.27 (s, 3H), 1.9-2.0 (m, 4H), 2.30 (d, J=7.8 Hz, 1H), 2.54 (q, J=11.8 Hz, 1H), 3.27 (m, 1H), 3.50 (m, 1H), 3.72 (t, J=7.4 Hz, 1H), 4.65 (q, J=7.4 Hz, 1H). ESI-MS m/z Positive 491 (M+H)+, Negative 549 (M+AcO)-. TLC (Merck, Kieselgel 60) Rf=0.33 (6:1 chloroform/methanol)
64% With hydrogenchloride; In methanol; at 20℃; for 168h; To <strong>[83207-58-3]astragaloside IV</strong> (1) (5.00 g, mmol) was added ?HCl-MeOH 10? (TCI America) (500 mL) and the mixture was stirred at room temperature for 7 days. The reaction mixture was concentrated to about half volume under reduced pressure at 20 C. (do not heat). The mixture was partitioned into aqueous sodium bicarbonate and ethyl acetate. The aqueous layer was extracted with ethyl acetate again. The organic layers were combined, washed with saturated sodium chloride, dried on anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography (20:114:1 chloroform/methanol). In order to replace the residual solvent with ethanol, the purified material was dissolved in ethanol and the solvent was removed under reduced pressure to afford 2 (2.1 g, 64%). (0173) 1H NMR (CDCl3) delta (ppm) 0.34 (d, J=4.7 Hz, 1H), 0.48 (d, J=4.3 Hz, 1H), 0.92 (s, 3H), 0.93 (s, 3H), 1.0-1.8 (m, 13H), 1.11 (s, 3H), 1.19 (s, 3H), 1.22 (s, 6H), 1.27 (s, 3H), 1.9-2.0 (m, 4H), 2.30 (d, J=7.8 Hz, 1H), 2.54 (q, J=11.8 Hz, 1H), 3.27 (m, 1H), 3.50 (m, 1H), 3.72 (t, J=7.4 Hz, 1H), 4.65 (q, J=7.4 Hz, 1H). ESI-MS m/z Positive 491 (M+H)+, Negative 549 (M+AcO)-. TLC (Merck, Kieselgel 60) Rf=0.33 (6:1 chloroform/methanol).
With hydrogenchloride; In methanol; chloroform; water; at 20℃; for 144h; 400 mg of <strong>[83207-58-3]astragaloside IV</strong> was taken as a raw material, and added to 400 ml of a 20% methanol aqueous solution having a volume fraction of 18% hydrochloric acid, and 640 ml of an organic phase chloroform was added.Stir vigorously for 6 days at room temperature, stand still after reaction, collect organic phase chloroform,The aqueous acid phase is neutralized by adding sodium hydrogencarbonate, and then an equal volume of chloroform is added for extraction.The combined organic phases were washed with a saturated aqueous solution of sodium chloride and dried over anhydrous sodium sulfate.Concentration under reduced pressure gave a crude material. The final cycloastragenol yield was calculated to be 46.28% by HPLC. Separation of cycloxanthine:200 mg of the above crude product was added to 600 mg of 200-300 mesh silica gel, and 8000 mg of silica gel was taken. The column was filled with chloroform in a wet manner, and the crude product mixed with silica gel was evenly dispersed on the top of the silica gel column, and then the volume ratio of chloroform:methanol was used. Elution was carried out at 15:1 with a flow rate of approximately 1.0 ml/min. The test was performed by thin layer chromatography every 10 ml of sampling. The eluent was collected and distilled under reduced pressure to give the product as a cyclohexanol having a purity of 99%.
  • 9
  • [ 223924-10-5 ]
  • [ 83207-58-3 ]
  • 10
  • [ 83207-58-3 ]
  • [ 86764-12-7 ]
YieldReaction ConditionsOperation in experiment
beta-glycosidase; In ethanol; water; at 45℃; for 24h;pH 5.0;Product distribution / selectivity; 150 ml medicinal ethanol was added to 2 g <strong>[83207-58-3]astragaloside IV</strong> to dissolve it while heating, and then water was added to dilute the resulting solution to 3000 ml, followed by the addition and dissolution of 30 g beta-glycosidase. Then the pH of the solution was adjusted to 5.0. The mixture was allowed to undergo enzymatic hydrolysis for 24 hours at a constant temperature of 45 C., and then filtered. The filtrate was subjected to adsorption using a 500 ml macroporous adsorption resin D101, and eluted successively with 2 column volumes of water, 0.5% sodium hydroxide solution and 30% ethanol solution respectively, and finally eluted with 2 column volumes of 70% ethanol, and the resulting eluent of 70% ethanol was collected, followed by vacuum concentration till no odour of alcohol can be detected, and a white precipitate was observed to settle out. The precipitate was obtained via filtration, and re-dissolved with 95% ethanol, then filtered, and the is filtrate was concentrated till the solution began to become turbid, and then kept for crystallization. The crystal, i.e., a purified CMG (white fine acicular powder), was obtained after filtration.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;